Approval · Notice of Compliance 27018 · 2021
BICNU: Notice of Compliance 27018
Issued November 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27018
- Date
- November 10, 2021
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site for the drug product.A ddition of an alternate supplier for glass vials. Addition of a primary container closure system. Change in the shelf life for the drug product. To convert the Product Monograph to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BICNU | Not yet assigned | — |
Medicinal ingredients
- CARMUSTINE 100 MG per VIAL